Wynne Davies-Weston
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Clinical severity classes in COVID-19 pneumonia have distinct immunological profiles, facilitating risk stratification by machine learning.
Journal: Frontiers in immunology
Published: March 23, 2023
Allergic eye disease: Blocking LTB4/C5 in vivo suppressed disease and Th2 & Th9 cells.
Journal: Allergy
Published: June 24, 2021
Dual inhibition of complement component 5 and leukotriene B4 by topical rVA576 in atopic keratoconjunctivis: TRACKER phase 1 clinical trial results.
Journal: Orphanet journal of rare diseases
Published: November 12, 2020
Leukotriene B4 and Its Receptor in Experimental Autoimmune Uveitis and in Human Retinal Tissues: Clinical Severity and LTB4 Dependence of Retinal Th17 Cells.
Journal: The American journal of pathology
Published: June 23, 2020
Successful treatment of a PNH patient non-responsive to eculizumab with the novel complement C5 inhibitor coversin (nomacopan).
Journal: British journal of haematology
Published: December 17, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026